Deccan Health Care delivered strong profitability growth in the June 2026 quarter, with consolidated net profit rising 20.83% to ₹0.29 crore compared to ₹0.24 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this growth came despite facing a slight revenue decline during the quarter.
The company's sales declined 0.32% to ₹22.07 crore in Q1 FY2026, down from ₹22.14 crore in the same quarter of the previous financial year. As reported by Business Standard, this marginal revenue decline suggests the company maintained its market position while focusing on operational efficiency improvements.
Operating profit margin (OPM) improved to 4.08% in the June 2026 quarter from 3.39% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion indicates better cost management and operational efficiency during the quarter.
Profit before depreciation and tax (PBDT) increased 4% to ₹0.77 crore from ₹0.74 crore in the previous year's quarter. As reported by Business Standard, profit before tax (PBT) grew 18% to ₹0.39 crore compared to ₹0.33 crore in Q1 FY2025, demonstrating consistent improvement across all profitability metrics despite the revenue decline.
As of August 14, 2026, Deccan Health Care Limited shares are trading at ₹12.81, down ₹0.66 from the previous closing. The stock has fluctuated between ₹12.81 and ₹13.78 during the session. Over the past year, the company has achieved a return of -30.22%, while the stock has gained 3.69% in the last month alone. The company's market capitalization stands at ₹30.01 crore with PE and PB ratios of 12.69 and 0.3 respectively. The stock has declined 4.97% from its previous close of ₹13.48, reflecting recent market volatility.
